Literature DB >> 21297078

Do cell junction protein mutations cause an airway phenotype in mice or humans?

Eugene H Chang1, Alejandro A Pezzulo, Joseph Zabner.   

Abstract

Cell junction proteins connect epithelial cells to each other and to the basement membrane. Genetic mutations of these proteins can cause alterations in some epithelia leading to varied phenotypes such as deafness, renal disease, skin disorders, and cancer. This review examines if genetic mutations in these proteins affect the function of lung airway epithelia. We review cell junction proteins with examples of disease mutation phenotypes in humans and in mouse knockout models. We also review which of these genes are expressed in airway epithelium by microarray expression profiling and immunocytochemistry. Last, we present a comprehensive literature review to find the lung phenotype when cell junction and adhesion genes are mutated or subject to targeted deletion. We found that in murine models, targeted deletion of cell junction and adhesion genes rarely result in a lung phenotype. Moreover, mutations in these genes in humans have no obvious lung phenotype. Our research suggests that simply because a cell junction or adhesion protein is expressed in an organ does not imply that it will exhibit a drastic phenotype when mutated. One explanation is that because a functioning lung is critical to survival, redundancy in the system is expected. Therefore mutations in a single gene might be compensated by a related function of a similar gene product. Further studies in human and animal models will help us understand the overlap in the function of cell junction gene products. Finally, it is possible that the human lung phenotype is subtle and has not yet been described.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21297078      PMCID: PMC3175552          DOI: 10.1165/rcmb.2010-0498TR

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  266 in total

1.  The air-liquid interface and use of primary cell cultures are important to recapitulate the transcriptional profile of in vivo airway epithelia.

Authors:  Alejandro A Pezzulo; Timothy D Starner; Todd E Scheetz; Geri L Traver; Ann E Tilley; Ben-Gary Harvey; Ronald G Crystal; Paul B McCray; Joseph Zabner
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-22       Impact factor: 5.464

Review 2.  A genecentric Human Protein Atlas for expression profiles based on antibodies.

Authors:  Lisa Berglund; Erik Björling; Per Oksvold; Linn Fagerberg; Anna Asplund; Cristina Al-Khalili Szigyarto; Anja Persson; Jenny Ottosson; Henrik Wernérus; Peter Nilsson; Emma Lundberg; Asa Sivertsson; Sanjay Navani; Kenneth Wester; Caroline Kampf; Sophia Hober; Fredrik Pontén; Mathias Uhlén
Journal:  Mol Cell Proteomics       Date:  2008-10       Impact factor: 5.911

3.  Deletion of the first pair of fibronectin type III repeats of the integrin beta-4 gene is associated with epidermolysis bullosa, pyloric atresia and aplasia cutis congenita in the original Carmi syndrome patients.

Authors:  Ramon Y Birnbaum; Daniella Landau; Khalil Elbedour; Rivka Ofir; Ohad S Birk; Rivka Carmi
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

4.  Salt and acid-base metabolism in claudin-16 knockdown mice: impact for the pathophysiology of FHHNC patients.

Authors:  Nina Himmerkus; Qixian Shan; Boeren Goerke; Jianghui Hou; Daniel A Goodenough; Markus Bleich
Journal:  Am J Physiol Renal Physiol       Date:  2008-09-10

5.  The role of integrin alpha8beta1 in fetal lung morphogenesis and injury.

Authors:  John T Benjamin; David C Gaston; Brian A Halloran; Lynn M Schnapp; Roy Zent; Lawrence S Prince
Journal:  Dev Biol       Date:  2009-09-19       Impact factor: 3.582

6.  beta6 Integrin subunit deficiency alleviates lung injury in a mouse model of bronchopulmonary dysplasia.

Authors:  Anna Hogmalm; Dean Sheppard; Urpo Lappalainen; Kristina Bry
Journal:  Am J Respir Cell Mol Biol       Date:  2009-08-28       Impact factor: 6.914

7.  A novel connexin50 mutation associated with congenital nuclear pulverulent cataracts.

Authors:  A Arora; P J Minogue; X Liu; P K Addison; I Russel-Eggitt; A R Webster; D M Hunt; L Ebihara; E C Beyer; V M Berthoud; A T Moore
Journal:  J Med Genet       Date:  2007-11-15       Impact factor: 6.318

8.  GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease.

Authors:  M Henneke; P Combes; S Diekmann; E Bertini; K Brockmann; A P Burlina; J Kaiser; A Ohlenbusch; B Plecko; D Rodriguez; O Boespflug-Tanguy; J Gärtner
Journal:  Neurology       Date:  2007-12-19       Impact factor: 9.910

9.  A novel M163L mutation in connexin 26 causing cell death and associated with autosomal dominant hearing loss.

Authors:  T D Matos; H Caria; H Simões-Teixeira; T Aasen; O Dias; M Andrea; D P Kelsell; G Fialho
Journal:  Hear Res       Date:  2008-04-03       Impact factor: 3.208

10.  A claudin-9-based ion permeability barrier is essential for hearing.

Authors:  Yoko Nakano; Sung H Kim; Hyoung-Mi Kim; Joel D Sanneman; Yuzhou Zhang; Richard J H Smith; Daniel C Marcus; Philine Wangemann; Randy A Nessler; Botond Bánfi
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more
  3 in total

Review 1.  Breaking barriers. New insights into airway epithelial barrier function in health and disease.

Authors:  Fariba Rezaee; Steve N Georas
Journal:  Am J Respir Cell Mol Biol       Date:  2014-05       Impact factor: 6.914

2.  Neutrophil elastase cleaves epithelial cadherin in acutely injured lung epithelium.

Authors:  Rachel Boxio; Julien Wartelle; Béatrice Nawrocki-Raby; Brice Lagrange; Laurette Malleret; Timothee Hirche; Clifford Taggart; Yves Pacheco; Gilles Devouassoux; Abderrazzaq Bentaher
Journal:  Respir Res       Date:  2016-10-17

3.  Claudin-7 modulates cell-matrix adhesion that controls cell migration, invasion and attachment of human HCC827 lung cancer cells.

Authors:  Do Hyung Kim; Qun Lu; Yan-Hua Chen
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.